Vrdoljak_2009_Basic.Clin.Pharmacol.Toxicol_105_401

Reference

Title : Irinotecan side effects relieved by the use of HI-6 oxime: in vivo experimental approach - Vrdoljak_2009_Basic.Clin.Pharmacol.Toxicol_105_401
Author(s) : Vrdoljak AL , Zunec S , Zeljezic D , Piljac-Zegarac J , Plestina S , Kuca K , Radic B , Mladinic M , Kopjar N
Ref : Basic Clin Pharmacol Toxicol , 105 :401 , 2009
Abstract : Vrdoljak_2009_Basic.Clin.Pharmacol.Toxicol_105_401
ESTHER : Vrdoljak_2009_Basic.Clin.Pharmacol.Toxicol_105_401
PubMedSearch : Vrdoljak_2009_Basic.Clin.Pharmacol.Toxicol_105_401
PubMedID: 19663821

Related information

Citations formats

Vrdoljak AL, Zunec S, Zeljezic D, Piljac-Zegarac J, Plestina S, Kuca K, Radic B, Mladinic M, Kopjar N (2009)
Irinotecan side effects relieved by the use of HI-6 oxime: in vivo experimental approach
Basic Clin Pharmacol Toxicol 105 :401

Vrdoljak AL, Zunec S, Zeljezic D, Piljac-Zegarac J, Plestina S, Kuca K, Radic B, Mladinic M, Kopjar N (2009)
Basic Clin Pharmacol Toxicol 105 :401